A Phase I, Open-label Study to Assess the Safety and Tolerability of AZD0530 in Combination With Carboplatin and/or Paclitaxel Chemotherapy in Patients With Solid Tumours.
Phase of Trial: Phase I
Latest Information Update: 21 Sep 2010
At a glance
- Drugs Carboplatin; Paclitaxel; Saracatinib
- Indications Solid tumours
- Focus Adverse reactions
- 21 Sep 2010 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
- 21 Sep 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Oct 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.